A monoclonal antibody stands out against omicron subvariants: a call to action for a wider access to bebtelovimab
Maxime Hentzien, Brigitte Autran, Lionel Piroth, Yazdan Yazdanpanah, Alexandra Calmy
Topics & Concepts
Monoclonal antibodyAuthorizationAntibodyCoronavirus disease 2019 (COVID-19)VirologySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)MedicineImmunologyInternal medicineComputer scienceComputer securityInfectious disease (medical specialty)DiseaseSARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research StudiesVirus-based gene therapy research